β-adrenergic augmentation of flecainide-induced conduction slowing in canine purkinje fibers

Circulation

Volumn 96, Issue 8, 1997, Pages 2701-2708

  Cragun, Kevin T ^a,b   Johnson, Susan B ^a   Packer, Douglas L ^a,b  

^a MAYO CLINIC   (United States)

^b ST MARY S HOSPITAL   (United States)

Author keywords

Flecainide; Isoproterenol; Receptors, adrenergic, beta; Sodium

Indexed keywords

BETA ADRENERGIC RECEPTOR; FLECAINIDE; ISOPRENALINE; SODIUM ION;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOG; DRUG POTENTIATION; FEMALE; HEART ARRHYTHMIA; HEART CONDUCTION; HEART DEPOLARIZATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PURKINJE FIBER;

EID: 0030809577     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.8.2701     Document Type: Article

References (57)

1. CAST Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction: the Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med. 1989;321: 406-412.
2. Anderson J, Platia E, Hallstrom A, Henthorn R, Buckingham T, Carlson M, Carson P. Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction: a possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST). Circulation. 1994;90:2843-2852.
3. Kennedy H, Brooks M, Barker A, Bergstrant R, Huther M, Beanlands D, Biller J, Goldstein CI. Beta-blocker therapy in the cardiac suppression trial. Am J Cardiol. 1994;74:674-680.
4. Myerburg RJ, Kessler KM, Cox MM, Huikuri H, Terracall E, Interian AJ, Fernandez P, Castellanos A. Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol. Circulation. 1989;80:1571-1579.
5. + currents by isoproterenol. Am J Physiol. 1990;258: H977-H982.
6. Schubert B, VanDongen AM, Kirsch GE, Brown AM. Beta-adrenergic inhibition of cardiac sodium channels by dual G-protein pathways. Science. 1989;245:516-519.
7. Ono K, Kiyosue T, Arita M. Isoproterenol, DBcAMP, and forskolin inhibit cardiac sodium current. Am J Physiol. 1989;256:C1131-C1137.
8. Ono K, Fozzard H, Hanck D. Mechanism of cAMP-dependent modulation of cardiac sodium channel current kinetics. Circ Res. 1993;72:807-815.
9. Kirstein M, Eickhorn R, Langenfeld H, Kochsiek K, Antoni H. Influence of β-adrenergic stimulation on the fast sodium current in the intact rat papillary muscle. Basic Res Cardiol. 1991;86:441-448.
10. Li M, West H, Numann R, Murphy B, Scheuer T, Catterall W. Convergent regulation of sodium channels by protein kinase C and cAMP-dependent protein kinase. Science. 1993;261:1439-1442.
11. Munger T, Johnson S, Packer D. Voltage dependence of β-adrenergic modulation of conduction in the canine Purkinje fiber. Circ Res. 1994;75:511-519.
12. Chen C, Gettes L. Combined effects of rate, membrane potential, and drugs on maximum rate of rise (Vmax) of action potential upstroke of guinea pig papillary muscle. Circ Res. 1976;1976: 464-469.
13. + activity in swine. Circulation. 1980;61: 768-778.
14. + increase and noradrenaline release as possible causes of early arrhythmias following acute coronary artery occlusion in pigs. J Mol Cell Cardiol. 1980;12:579-593.
15. Lammerant J, DeHert P, DeSchryver C. Direct release of catecholamine into the left heart chambers: the enhancing effect of acute coronary occlusion. Arch Int Pharmacodyn Ther. 1966;163:219-229.
16. Kinnaird A, Lederman C, Man R. Electrophysiological actions of flecainide in normal and infarcted canine Purkinje fibers. Eur J Pharmacol. 1985;112:57-64.
17. Ikeda N, Singh BN, Davis LD, Hauswirth O. Effects of flecainide on the electrophysiologic properties of isolated canine and rabbit myocardial fibers. J Am Coll Cardiol. 1985;5:303-310.
18. Anno T, Hondeghem L. Interactions of flecainide with guinea pig cardiac sodium channels. Circ Res. 1990;66:789-803.
19. Konzen G, Reichardt B, Hauswirth O. Fast and slow blockade of sodium channels by flecainide in rabbit cardiac Purkinje fibers. Naunyn Schmiedebergs Arch Pharmacol. 1990;341:565-576.
20. Buchanan JJ, Saito T, Gettes L. The effects of antiarrhythmic drugs, stimulation frequency, and potassium-induced resting membrane potential changes on conduction velocity and dV/dtmax in guinea pig myocardium. Circ Res. 1985;56:696-703.
21. Packer DL, Grant AO, Strauss HC, Starmer CF. Characterization of concentration- and use-dependent effects of quinidine from conduction delay and declining conduction velocity in canine Purkinje fibers. J Clin Invest. 1989;83:2109-2119.
22. + channel kinetic changes by cAMP and isoproterenol in canine cardiac ventricular cells. Biophys J. 1992;61:A112. Abstract.
23. Matsuda JJ, Lee H, Shibata EF. Enhancement of rabbit cardiac sodium channels by beta-adrenergic stimulation. Circ Res. 1992;70: 199-207.
24. + channel required for modulation by protein kinase C. Science. 1991;254:866-868.
25. Cragun K, Johnson S, Packer D. Direct characterization of flecainide binding rates from use-dependent conduction delay in canine Purkinje fibers. J Am Coll Cardiol. 1995;25:284A. Abstract.
26. DeMellIo W. Effect of isoproterenol and 3-isobutyl-1-methylxanthine on junctional conductance in heart cell pairs. Biochim Biophys Acta. 1989;1012:291-298.
27. DeMello W. Further studies on the influence of cAMP-dependent protein kinase on junctional conductance in isolated heart cell pairs. J Mol Cell Cardiol. 1991;23:371-379.
28. Spray D, Burt J. Structure-activity relations of the cardiac gap junction channel. Am J Physiol. 1990;258:C195-C205.
29. Hisatome I, Kiyosue T, Imanishi S, Arita M. Isoproterenol inhibits residual fast channel via stimulation of beta-adrenoceptors in guinea-pig ventricular muscle. J Mol Cell Cardiol. 1985;17:657-665.
30. Hashimoto K, Moe GK. Effect of external potassium and acetylstrophanthidin on conduction velocity of isolated canine Purkinje fibers. Jpn J Pharmacol. 1985;37:355-363.
31. + channels expressed in a mammalian cell line and in ventricular myocytes by protein kinase C. Proc Natl Acad Sci USA. 1994;91:3289-3293.
32. + channel. Circ Res. 1997;80:370-376.
33. Li M, West JW, Lai Y, Scheuer T, Catterall WA. Functional modulation of brain sodium channels by cAMP-dependent phosphorylation. Neuron. 1992;8:1151-1159.
34. + channel alpha subunit by cAMP-dependent protein kinase and phosphoprotein phosphatases. J Biol Chem. 1993;268: 27355-27362.
35. ++ concentration in rat heart. Am J Physiol. 1987.
36. ++), on nexal membrane resistance. Pflugers Arch. 1987;409:394-402.
37. Spray DC, White RL, Mazet F, Bennett MVL. Regulation of gap junctional conductance. Am J Physiol. 1985;248:H753-H764.
38. Nitta J, Sunami A, Marumo F, Hiraoka M. States and sites of actions of flecainide on guinea-pig cardiac sodium channels. Eur J Pharmacol. 1992;214:191-197.
39. Lee HC, Matsuda JJ, Reynertson SI, Martins JB, Shibata EF. Reversal of lidocaine effects on sodium currents by isoproterenol in rabbit hearts and heart cells. J Clin Invest. 1993;91:693-701.
40. 2 from Vmax. Pacing Clin Electrophysiol. 1991;14:726.
41. Newman D, Herre J, Chin M, Garcia J, Franz M, Sheinman M, Katzung B. Effects of sympathetic tone and action potential duration on in vivo use-dependence. Circulation. 1988;78(suppl II): 11-146. Abstract.
42. Avitall B, Hare J, Tchou P, Jazayeri M, Akhtar M. Flecainide toxicity: reversal of drug effects by isoproterenol infusion. J Cardiovasc Electrophysiol. 1991;2:431-440.
43. Morady F, Kou WH, Kadish AH, Nelson SD, Toivonen LK, Kushner JA, Schmaltz S, deBuitleir M. Antagonism of quinidine's electrophysiologic effects by epinephrine in patients with ventricular tachycardia. J Am Coll Cardiol. 1988;12:388-394.
44. Sager P, Ahmen R, Behboodikhah M, Follmer C, Pruitt C, Singh B. Differential electrophysiologic actions of beta-adrenergic stimulation on sotalol and quinidine in humans. J Am Coll Cardiol. 1993;21:245A. Abstract.
45. Jazayeri MR, Van WG, Avitall B, McKinnie J, Tchou P, Akhtar M. Isoproterenol reversal of antiarrhythmic effects in patients with inducible sustained ventricular tachyarrhythmias. J Am Coll Cardiol. 1989;14:705-711.
46. Niazi I, Naccarelli G, Dougherty A, Rinkenberger R, Tchou P, Akhtar M. Treatment of atrioventricular node reentrant tachycardia with encainide: reversal of drug effect with isoproterenol. J Am Coll Cardiol. 1989;13:904-910.
47. Markel M, Miles W, Luck J, Klein L, Prystowsky E. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy. Circulation. 1993;87:783-792.
48. Grant A, Trantham J, Brown K, Strauss H. pH-dependent effects of quinidine on the kinetics of dV/dtmax in guinea pig ventricular myocardium. Circ Res. 1982;50:210-217.
49. Hille B. The pH-dependent rate of action of local anesthetics on the node of Ranvier. J Gen Physiol. 1977;69:475-496.
50. Ranger S, Nattel S. Determinants and mechanisms of flecainide-induced promotion of ventricular tachycardia in anesthetized dogs. Circulation. 1995;92:1300-1311.
51. Coromilas J, Saltman A, Waldecker B, Dillon S, Wit A. Electrophysiological effects of flecainide on anisotropic conduction and reentry in infarcted canine hearts. Circulation. 1995;91: 2245-2263.
52. Starmer C, Lastra A, Nesterenko V, Grant A. Proarrhythmic response to sodium channel blockade: theoretical model on numerical experiments. Circulation. 1991;84:1364-1377.
53. Brugada J, Boersma L, Kirchhof C, Allessie M. Proarrhythmic effects of flecainide: experimental evidence for increased susceptibility to reentrant arrhythmias. Circulation. 1991;84:1808-1818.
54. Brugada J, Boersma L, Kirchhof C, Brugada P, Havenith M, Wellens H, Allessie M. Double-wave reentry as a mechanism of acceleration of ventricular tachycardia. Circulation. 1990;81: 1633-1643.
55. Peters RW, Muller JE, Goldstein S, Byington R, Friedman LM. Propranolol and the morning increase in the frequency of sudden cardiac death (BHAT Study). Am J Cardiol. 1989;63:1518-1520.
56. Turton M, Deegan T. Circadian variations of plasma catecholamine, cortisol, and immunoreactive insulin concentrations in supine subjects. Clin Chim Acta. 1974;55:389-397.
57. + current and phase of the action potential in isolated cardiac myocytes. Circ Res. 1994;75:491-502.